Analysts feel exclusivity on Glumetza generic & full quarter of price hikes on Fortamet generic may drive US numbers.
Lupin had launched Fortamet, a diabetic drug, at risk in the US, causing an injunction against the drug. Chief Financial Officer S Ramesh clarified that Fortamet generic was launched only for few days.
Lupin has launched Fortamet Generic at risk in the US, reports CNBC-TV18. It touched an intraday high of Rs 466 and an intraday low of Rs 454.90. At 15:14 hrs the share was quoting at Rs 454.90, down Rs 8.65, or 1.87%.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.